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Abstract 
Background: Melkersson–Rosenthal syndrome is a rare, neuro-mucocutaneous, granulomatous disorder of 
unknown etiology, clinically characterized by a triad of symptoms: recurrent facial nerve palsy, facial swelling and 
fissured tongue. Melkersson–Rosenthal syndrome is frequently seen in patients in their second or third decade of 
life. It is diagnosed based on clinical features, and it is rarely possible to observe all the classic triad symptoms at 
the same time. The disorder may cause recurring peripheral facial palsy that is wrongly diagnosed as recurrent Bell’s 
palsy. 
Case presentation: A 25-year-old female patient, referred from Bishoftu town in Ethiopia, was presented to the 
neurology clinic of Tikur Anbessa Specialized Hospital in Addis Ababa complaining of a five-day history of 
recurrent left-side peripheral facial weakness, facial edema and fissured tongue. Her past medical history was 
positive for similar symptoms, for which she was diagnosed with Bell’s palsy and received oral corticosteroid 
treatment. Left-side lower facial swelling with flat naso-labial fold and fissured tongue were detected on 
examination. After excluding other mimickers, she was diagnosed with Melkersson–Rosenthal syndrome and 
completely recovered with a high dose of steroid treatment.  
Conclusion: Melkersson–Rosenthal syndrome may present with the classic clinical triads of symptoms, but mostly 
it shows an oligosymptomatic pattern. So, it is usually under-recognized and often misdiagnosed as Bell’s palsy, as 
had been done in the past in our case. Therefore, Melkersson–Rosenthal syndrome should be considered in the 
differential diagnosis of patients presented with recurrent peripheral facial weakness, as early detection and therapy 
might prevent cosmetic disfigurement from multiple relapses [Ethiop. J. Health Dev. 2020; 34(3): 214-216] 
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Introduction 
Melkersson–Rosenthal syndrome (MRS) is a rare, 
neuro-mucocutaneous disorder characterized by a triad 
of symptoms: recurrent peripheral facial nerve palsy, 
facial and/or lip swelling and fissured tongue (1). 
Although the exact cause of MRS has not been 
recognized, genetic predisposition, allergic reaction, 
hypersensitivity, and autoimmune and microbial 
reactions have been hypothesized to contribute to its 
pathogenesis (2).  
 
Patients with underlying granulomatous conditions 
might present with facio-labial swelling, and recurrent 
facial weakness could be attributed to other systemic 
disorders, such as diabetes mellitus and hypothyroidism. 
Hence, MRS is the diagnosis of exclusion.  
 
This case study is of a young female, referred from 
Bishoftu town on May 30, 2019, who was presented to 
the neurology clinic at Tikur Anbessa Specialized 
Hospital in Addis Ababa with a complaint of third-time 
recurrence of left-side peripheral facial weakness and 
facial edema for a duration of five days. Her past 
medical history revealed similar symptoms, which were 
diagnosed as Bell’s palsy.  
 
Case presentation 
A 25-year-old black female patient was referred from 
Bishoftu town and presented to the neurology clinic of 
Tikur Anbessa Specialized Hospital in Addis Ababa on 
May 30, 2019. Her main complaint was an insidious 
onset, left upper lip, painless swelling, which progressed 
to involve her left cheek. She had been unable to close 
her left eyelid for the previous five days. Her past 
medical history was positive for two episodes of same-
side peripheral facial weakness. During the first attack, 
in 2016, her symptoms spontaneously resolved without 
any treatment. But when it recurred two years later, she 
visited a nearby clinic, and was diagnosed as a case of 
recurrent Bell’s palsy, which showed a complete 
resolution following corticosteroid treatment. She did 
not recall any cause or inciting factor that had induced 
her symptoms. She had no history of trauma to the head 
or neck region, skin rash or sensory symptoms. She 
denied any recent history of infection of the ear, throat, 
sinus or dental structure. She had no personal history of 
sarcoidosis, Crohn’s disease, autoimmune condition or 
any other chronic illness, and her family history was 
negative for similar conditions. She denied any history 
of food allergy or any other form of allergic reaction in 
the past. 
 
Her physical examination demonstrated a diffuse, non-
pitting swelling of the left cheek with peri-orbital 
fullness (see Figure 1), fissured tongue (lingua plicata) 
and mild left naso-labial fold flattening (see Figure 2). 
The clinical and laboratory evaluations for possible 
cause of recurrent peripheral facial palsy, including 
diabetes mellitus, otitis media, syphilis, Guillain–Barré 
syndrome, leukemia or other tumors, was non-revealing. 
Magnetic resonance imaging (MRI) of the head (see 
Figure 3) showed a normal brain parenchyma and clear 
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Figure 1: Patient had a diffuse swelling of the 
left cheek and lower eyelid  
 
 
Figure 2: Patient had a fissured tongue and 
mild flattening of the left naso-labial fold  
 
 
Figure 3: A T2-weighted axial brain MRI showed 
a normal brain parenchyma with a clear course 
of the facial nerve intra-cranial segment 
 
She was initiated on oral prednisolone therapy at 1 
mg/kg/day, with gradual tapering for three weeks. Her 
facial edema completely subsided by the third day of 
treatment and facial weakness recovered by the second 
week. Therefore, a final diagnosis of MRS was made 




MRS is a neuro-mucocutaneous syndrome belonging to 
the orofacial granulomatosis group. The condition was 
first reported by Melkersson in 1928, where a woman 
with intermittent peripheral facial palsy and lip edema 
was documented (3). Later, in 1931, Rosenthal 
completed the triad of symptoms of the syndrome by 
adding the presence of fissured tongue (4).  
 
MRS is a rare syndrome with an estimated incidence of 
0.08% in the general population. Disease onset is more 
frequent in young adults, between the second and third 
decades of life, and a relatively higher rate is seen in 
females (5). Our case was of a young female in her early 
20s during symptom onset. 
 
The etiology of MRS remains uncertain, but it has been 
postulated that genetics, infectious and immunologic 
factors may play an etiologic role (6). There are reports 
of MRS associated with viral and other bacterial 
infections, autoimmunity, neurotropic factors, atopy and 
hypersensitivity reactions to various antigens, including 
food additives such as monosodium glutamate, which 
may have a pathogenesis effect but has not been 
confirmed as an etiologic agent (1).  
   
The classic triad of recurring facial paralysis, 
fissured/scrotal tongue and recurring orofacial and/or lip 
edema is observed in only 8% to 25% of MRS patients 
(1). Recurring lip and/or orofacial edema is the most 
common presenting symptom, in 80% to 100% of 
patients (7). The facial edema is generally painless, 
unilateral, and most often occurs in the upper lip. Less 
frequently, edema may involve cheeks, palate, gingiva, 
tongue, pharynx, larynx, and periorbital region (8). 
Facial paralysis is observed in 47%-90% of cases and 
can be transient or sometimes permanent. It is most 
often unilateral but rarely can be bilateral, and the 
recurrence rate is around 10% (6). Oligosymptomatic 
forms are reported in around 50% of cases, while the 
combination of orofacial edema and facial palsy was 
seen by Chan et al in 22% of cases. (9). In 40% of MRS 
patients, fissured tongue (lingua plicata) is identified 
(10). The classic triad symptoms are observed in less 
than a quarter of MRS patients, so this make clinical 
diagnosis very difficult. In the present case, the woman 
was wrongly diagnosed, in the past, with recurrent 
Bell’s palsy. 
 
The diagnosis of MRS is difficult, as there are no 
acknowledged diagnostic criteria or biomarkers to test. 
Many authors agree that MRS is a clinical syndrome that 
is diagnosed by a constellation of sign and symptoms 
with no need for further investigation. But in 
oligosymptomatic cases, the diagnosis is confirmed by 
histopathological examination showing non-caseating 
granulomas (11). However, as shown in our case, subtle 
features – such as fissured tongue and a complete 
resolution of symptoms – support the diagnosis of MRS 
after possible mimickers were excluded following 
extensive investigation. 
 
The differential diagnosis of MRS includes a broad 
spectrum of heterogeneous conditions, mainly 
represented by other granulomatous disorders, such as 
allergic reactions and contact dermatitis, sarcoidosis, 
Crohn’s disease, Wegener’s vasculitis and amyloidosis. 
Causes of recurrent facial palsy, including 
hypothyroidism, lymphangioma, erysipelas, lymphoma 
and herpes simplex labialis, should be considered in the 
differential diagnosis; Bell’s palsy, orofacial herpes, 
rosacea, and allergic reactions should also be considered 
(6-8). 
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Although there is no definite treatment for the disease 
and recurrences are unavoidable, we have options of 
therapy, including antihistamines, methotrexate, 
systemic and/or intra-lesional steroid administrations, 
which can improve or cure orofacial edema and are 
considered as initial choices (12). Surgical options are 
available for refractory facial edema with significant 
deformity of the face (13). 
 
Conclusion 
To the best of the author’s knowledge, this is the first 
case of MRS reported in Ethiopia. It highlights the 
importance of considering MRS in the differential 
diagnosis of recurrent peripheral facial nerve paralysis, 
and to look for other subtle clinical features such as 
tongue fissures, since most MRS patients present with 
an oligosymptomatic pattern. Early detection and timely 
management can reduce relapse and prevent deformity. 
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